The new sparkling DIME (Digi MarketEr) are the ones who embrace digital transformation with open arms and voraciously feed on data analytics to satisfy their performance outcomes with an informed business decision. The benefit of being DIME is that it propels data management out of the hands of individual stakeholders, and puts data sets with insights on to center glass table (Transparent workplace) for informed decision making.

You can Lead People

Articles by K. Hariram, Vivek Hattangadi, Hanno Wolfram, Soham Wagh and Amit Jain

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Marketing

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Policies/Sales

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Strategy

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

Digital Darwinism or Digital Expert – The Choice for Indian Pharma is Clear

It is heartening to see that Pharma marketers have...

India’s Hospital Acquisitions Surge: RCML’s Pratiksha Deal Signals Expansion and Industry Trends

The healthcare sector in India has entered a dynamic...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Is Pharma’s Business Model like McDonald’s? ...

Is Pharma’s business model like McDonald’s? Doing things over & over again without innovation? McDonald’s is famous for its Hamburger University, a training facility at the McDonald’s Corporation global headquarters in Chicago, Illinois. It instructs high-potential restaurant managers in restaurant management. More than 5,000 students attend Hamburger University each year and over 275,000 people have graduated with a degree in Hamburgerology. Sound familiar? Pharma’s training has been on similar lines – hire people continuously and put them through the grind of mugging up essentials of drugs for diseases that the particular company sells. While the McDonald’s model is ideal for its business of replication, it has outlived its utility in healthcare and drug companies are in danger of being reduced to mere suppliers of drugs to new digital platform businesses unless they learn to innovate.